Allergy Asthma Immunol Res.  2016 Sep;8(5):457-460. 10.4168/aair.2016.8.5.457.

Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria

• Bae Y
• Izuhara K
• Ohta S
• Ono J
• Hong GU
• Ro JY
• Park GH
• Choi JH

• KMID: 2295155
• DOI: http://doi.org/10.4168/aair.2016.8.5.457

Abstract

Chronic spontaneous urticaria (CSU) is a complex idiopathic disease of the skin with various cellular infiltrations. Although mast cells are key effector cells in the pathogenesis of CSU, CD4+ T helper 2 cells also have particular roles in the development and maintenance of CSU. Periostin is known as a downstream molecule of interleukin (IL)-4 and IL-13, key cytokines of type 2 immune responses. In this study, we examined periostin and IL-13 levels in the sera of patients with CSU (n=84) and healthy normal controls (NCs, n=43). Periostin levels were significantly lower in the CSU group than in NCs (71.4±21.8 vs 85.1±22.4 ng/mL, P=0.04). Periostin levels were also lower in the severe CSU group than those in mild CSU (59.7±18.0 vs 73.4±22.0 ng/mL, P=0.04). However, IL-13 levels were significantly higher in patients with CSU than in NCs (508.5±51.2 vs 200.7±13.3 pg/mL, P=0.001). In conclusion, periostin and IL-13 may be independently related to the pathogenesis of CSU.

Keyword

Urticaria; periostin; interleukin-13

MeSH Terms

Cytokines
Humans
Interleukin-13*
Interleukins
Mast Cells
Skin
Urticaria*
Cytokines
Interleukin-13
Interleukins

Figure

• 

  Fig. 1 (A) Serum periostin and (B) IL-13 levels in CSU patients and NCs. CSU, chronic spontaneous urticaria; NCs, normal controls.

• 

  Fig. 2 Comparison of periostin levels according to disease severity in CSU patients.

Reference

1. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2014; 69:e1–e29.

2. Losol P, Yoo HS, Park HS. Molecular genetic mechanisms of chronic urticaria. Allergy Asthma Immunol Res. 2014; 6:13–21.

3. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002; 109:694–700.

4. Zweiman B, Haralabatos IC, Pham NC, David M, von Allmen C. Sequential patterns of inflammatory events during developing and expressed skin late-phase reactions. J Allergy Clin Immunol. 2000; 105:776–781.

5. Ferrer M, Luquin E, Sanchez-Ibarrola A, Moreno C, Sanz ML, Kaplan AP. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol. 2002; 129:254–260.

6. Caproni M, Cardinali C, Giomi B, Antiga E, D'Agata A, Walter S, et al. Serological detection of eotaxin, IL-4, IL13, INF-γ, MIP-1α, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J Dermatol Sci. 2004; 36:57–59.

7. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006; 118:98–104.

8. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 2012; 130:647–654.e10.

9. Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest. 2012; 122:2590–2600.

10. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012; 18:716–725.

11. Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. Allergol Int. 2014; 63:143–151.

12. Kou K, Okawa T, Yamaguchi Y, Ono J, Inoue Y, Kohno M, et al. Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol. 2014; 171:283–291.

13. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009; 64:1256–1268.

14. Kay AB, Clark P, Maurer M, Ying S. Elevations in Th2-initiating cytokines (IL-33, IL-25, TSLP) in lesional skin from chronic spontaneous ("idiopathic") urticaria. Br J Dermatol. 2014; 172:1294–1302.

15. Yang L, Murota H, Serada S, Fujimoto M, Kudo A, Naka T, et al. Histamine contributes to tissue remodeling via periostin expression. J Invest Dermatol. 2014; 134:2105–2113.